Claims for Patent: 9,155,700

Summary for Patent: 9,155,700

Title:	Process for the preparation of pharmaceutical suspensions for inhalation
Abstract:	Process for preparing sterile suspensions for inhalation comprising an active ingredient insoluble in water and wherein at least 80% of the particles of said active ingredient have a diameter between 3 and 5 .mu.m, comprising the following stages: dissolving the active ingredient in the minimum quantity of an alcoholic solvent, optionally in the presence of a polyol and adding at least one surfactant, filtering the solution obtained in the previous stage through a sterilizing filter, adding the solution from stage (b) to sterile water under sonication to directly obtain a suspension wherein the particles have a reduced diameter.
Inventor(s):	Ronchi; Celestino (Milan, IT), Ceschel; Giancarlo (Milan, IT)
Assignee:	CHIESI FARMACEUTICI S.p.A. (Parma, IT)
Application Number:	13/332,756
Patent Claims:	1. A sterile pharmaceutical inhalable aqueous suspension for treating asthma, consisting essentially of particles of an active ingredient insoluble in water selected from the group consisting of beclomethasone dipropionate (BDP), budesonide and salbutamol in a concentration between 0.01 and 0.1% by weight, an alcohol in a concentration between 0.01 and 0.1%, polyol in a concentration between 0.04 and 0.4%, a surfactant selected from the group consisting of ethoxylated castor oil, sorbitan trioleate, oleic alcohol, lecithin oleic acid, and polysorbates in a concentration between 0.04 and 0.4%, the remaining to 100 parts by weight consisting of sterile water, wherein at least 80% of the particles of said active ingredient insoluble in water have a diameter between 3 and 5 .mu.m. 2. The sterile suspension of claim 1, wherein said alcohol is ethanol. 3. The sterile suspension of claim 1, wherein said polyol is propylene glycol. 4. The sterile suspension of claim 1, wherein said surfactant is ethoxylated castor oil. 5. The sterile suspension of claim 1, consisting essentially of 0.04% of the active ingredient, 0.15% of ethoxylated castor oil, 0.04% of ethanol, 0.15% of propylene glycol, and sterile water q.s. to 100 parts by weight.

Details for Patent 9,155,700

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2023-10-22